35.54BMarket Cap-105.17P/E (TTM)
277.220High263.010Low686.45KVolume266.850Open266.540Pre Close187.53MTurnover0.54%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High1097.77P/B35.39BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM5.33%Amplitude3.650Historical Low273.194Avg Price1Lot Size
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet